BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34811625)

  • 1. Effect of Insulin Receptor-Knockdown on the Expression Levels of Blood-Brain Barrier Functional Proteins in Human Brain Microvascular Endothelial Cells.
    Nagano H; Ito S; Masuda T; Ohtsuki S
    Pharm Res; 2022 Jul; 39(7):1561-1574. PubMed ID: 34811625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of Podocalyxin Post-Transcriptionally Induces the Expression and Activity of ABCB1/MDR1 in Human Brain Microvascular Endothelial Cells.
    Nagano H; Ogata S; Ito S; Masuda T; Ohtsuki S
    J Pharm Sci; 2022 Jun; 111(6):1812-1819. PubMed ID: 35182544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
    Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells.
    Shubbar MH; Penny JI
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2314-2322. PubMed ID: 30048740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease.
    Arduino I; Iacobazzi RM; Riganti C; Lopedota AA; Perrone MG; Lopalco A; Cutrignelli A; Cantore M; Laquintana V; Franco M; Colabufo NA; Luurtsema G; Contino M; Denora N
    Int J Pharm; 2020 Dec; 591():120011. PubMed ID: 33115695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study.
    Storelli F; Billington S; Kumar AR; Unadkat JD
    Clin Pharmacol Ther; 2021 Mar; 109(3):667-675. PubMed ID: 32885413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
    Ohtsuki S; Ikeda C; Uchida Y; Sakamoto Y; Miller F; Glacial F; Decleves X; Scherrmann JM; Couraud PO; Kubo Y; Tachikawa M; Terasaki T
    Mol Pharm; 2013 Jan; 10(1):289-96. PubMed ID: 23137377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in ABCG2 mRNA Expression in Human Immortalised Brain Microvascular Endothelial Cells by Ferric Ammonium Citrate is Mediated by Reactive Oxygen Species and Activation of ERK1/2 Signalling.
    Newman SA; Short JL; Nicolazzo JA
    Pharm Res; 2023 Mar; 40(3):651-660. PubMed ID: 36539667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model.
    Versele R; Sevin E; Gosselet F; Fenart L; Candela P
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
    Hoque MT; Shah A; More V; Miller DS; Bendayan R
    J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
    Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
    Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies.
    Poller B; Gutmann H; Krähenbühl S; Weksler B; Romero I; Couraud PO; Tuffin G; Drewe J; Huwyler J
    J Neurochem; 2008 Dec; 107(5):1358-68. PubMed ID: 19013850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
    Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
    Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice.
    Gali CC; Fanaee-Danesh E; Zandl-Lang M; Albrecher NM; Tam-Amersdorfer C; Stracke A; Sachdev V; Reichmann F; Sun Y; Avdili A; Reiter M; Kratky D; Holzer P; Lass A; Kandimalla KK; Panzenboeck U
    Mol Cell Neurosci; 2019 Sep; 99():103390. PubMed ID: 31276749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Combination of Clioquinol, Zinc and Copper Increases the Abundance and Function of Breast Cancer Resistance Protein in Human Brain Microvascular Endothelial Cells.
    Yap C; Short JL; Nicolazzo JA
    J Pharm Sci; 2021 Jan; 110(1):338-346. PubMed ID: 32339529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic Cation Transporters are Involved in Fluoxetine Transport Across the Blood-Brain Barrier
    Wang M; Sun Y; Hu B; He Z; Chen S; Qi D; An H; Wei Y
    Curr Drug Deliv; 2022; 19(4):508-517. PubMed ID: 34238184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.
    Bakhsheshian J; Wei BR; Chang KE; Shukla S; Ambudkar SV; Simpson RM; Gottesman MM; Hall MD
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20801-6. PubMed ID: 24297888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor regulates CYP1B1 but not ABCB1 and ABCG2 in hCMEC/D3 human cerebral microvascular endothelial cells after TCDD exposure.
    Jacob A; Potin S; Chapy H; Crete D; Glacial F; Ganeshamoorthy K; Couraud PO; Scherrmann JM; Declèves X
    Brain Res; 2015 Jul; 1613():27-36. PubMed ID: 25858487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.